Medicinal Research W8 Flashcards

1
Q

What does off-labeling prescription treat?

A

Treating a patient who has a condition for which the product does not have a marketing authorisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Revocation, variation or suspension of marketing authorisation when…

A

Harmful or ineffective
Incorrect information
Breach of licence
Unfulfilled licence
No longer EU based
Non compliance with good manufacturing practice (GMP)
Unfulfilled licence (not uk)
Public at risk
Apply for a change
Poor manufacturing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When are orphan drugs used?

A

Used to treat conditions that occur infrequently
Cost of R and D would not be recovered by the expected sales

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do you qualify as an orphan drug?

A

For a disease that is life threatening or chronically debilitating
Not more than 5 in 10,000
No satisfaction method exists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the qualifications for branded drugs when comparing with generic drugs?

A

Have the same composition as References Medicinal Products
Has the same pharmaceutical form
Appropriate bioavailability studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are branded generics?

A

Generics that have a branded name
Encourage medical practitioners to prescribe branded generics which have a lower cost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the data exclusivity period ?

A

Period of eight years for products that have been authorised in the UK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is early access to medicines scheme (EAMS)?

A

Enables patients to have access to medicines which have not yet been authorised.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is pharmacovigilance?

A

Detection, assessment, understanding and prevention of adverse effects or any other drug-related problems.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Who must operate pharmacovigilance?

A

The licensing authority
Holders of manufacturing authorisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the yellow card scheme?

A

MHRA collects and monitors information on suspected concerns or incidents involving medicines and medical devices.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Who is the regulatory body of the pharmacy profession?

A

GPhC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the structure of the GPhC?

A

Has a chair and 13 other members of the council appointed by the public appointments commission.
Seven members are registrants and seven are lay men.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Where does the GPhC have regulatory powers?

A

England, Scotland and Wales
Not Northern Ireland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does the GPhC do?

A

Register
Standards for pharmacies
Fitness to practice
Standards for pharmacists
Education/ training

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Who can be a superintendent pharmacist?

A

Must be a pharmacist
Cannot be the superintendent pharmacist of more than one business at the same time
Keeping, preparing and dispensing products